Fig. 8From: A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learningMacrophages-related signature (MRS)-based treatment strategy for ovarian cancer. Comparison of risk score in CR/PR and SD/PD group and corresponding ROC curve in GSE91061 (A) and IMvigor210 (C) cohort. The OS curve in patients with high and low risk score in GSE91061 (B) and IMvigor210 (D) cohortBack to article page